Tracking Technologies Guard Vaccine Cold Chain

Now that COVID-19 vaccines have received regulatory authorizations and vaccine manufacturers are providing a steady and increasing supply, the focus is on distributing doses. Vaccine manufacturers worked closely with cold-chain distribution experts to plan for maintaining and monitoring the cold chain for these crucial drug products. Pharmaceutical Technology spoke with Mahesh Veerina, CEO of Cloudleaf, and Gisli Herjolfssonn, CEO and cofounder of Controlant, about supply-chain visibility systems for maintaining the cold chain.

Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.

About the Author

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 38–43

Citation

When referring to this article, please cite it as J. Markarian, “Tracking Technologies Safeguard Vaccine Cold Chain" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).